Similar articles

• Qualitative alterations in urinary 17-ketosteroid excretion during aminoglutethimide administration.

  Horký K, Küchel O, Gregorvá I, Stárka L. Horký K, et al. J Clin Endocrinol Metab. 1969 Feb;29(2):297-9. doi: 10.1210/jcem-29-2-297. J Clin Endocrinol Metab. 1969. PMID: 4236926 Clinical Trial. No abstract available.
• Effect of aminoglutethimide on urinary steroid excretion in patients with congenital adrenal hyperplasia due to incomplete 21-hydroxylase deficiency.

  Horký K, Kuchel O, Gregorová I, Stárka L. Horký K, et al. Metabolism. 1972 Apr;21(4):305-12. doi: 10.1016/0026-0495(72)90074-1. Metabolism. 1972. PMID: 4334310 Clinical Trial. No abstract available.
• [Effect of aminoglutethimide on the excretion of total neutral 17-ketosteroids and their fractions].

  Horký K, Küchel O, Gregorová I. Horký K, et al. Cas Lek Cesk. 1968 Jul 12;107(29):888-91. Cas Lek Cesk. 1968. PMID: 5664851 Czech. No abstract available.
• Evidence suggesting 11 beta-hydroxylase inhibition during aminoglutethimide administration.

  Faglia G, Gattinoni L, Travaglini P, Neri V, Acerbi L, Ambrosi B. Faglia G, et al. Metabolism. 1971 Mar;20(3):266-72. doi: 10.1016/0026-0495(71)90109-0. Metabolism. 1971. PMID: 5546922 No abstract available.
• [Inhibition of adrenocortical steroid production in therapy].

  Bricaire H, Philbert M, Luton JP. Bricaire H, et al. Rev Fr Etud Clin Biol. 1968 Jun-Jul;13(6):563-7. Rev Fr Etud Clin Biol. 1968. PMID: 4178146 Review. French. No abstract available.